Applied Therapeutics, Inc.

Applied Therapeutics, Inc.verified

APLT

Price:

$4.5

Market Cap:

$514.20M

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products in...[Read more]

Industry

Biotechnology

IPO Date

2019-05-14

Stock Exchange

NASDAQ

Ticker

APLT

The PE Ratio as of June 2024 (TTM) for Applied Therapeutics, Inc. (APLT) is -2.36

According to Applied Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.36. This represents a change of 46.98% compared to the average of -1.61 of the last 4 quarters.

Applied Therapeutics, Inc. (APLT) Historical PE Ratio (quarterly & annually)

How has APLT PE Ratio performed in the past?

The mean historical PE Ratio of Applied Therapeutics, Inc. over the last ten years is -6.16. The current -2.36 PE Ratio has changed 3.73% with respect to the historical average. Over the past ten years (40 quarters), APLT's PE Ratio was at its highest in in the June 2022 quarter at -0.19. The PE Ratio was at its lowest in in the March 2020 quarter at -13.77.

Quarterly (TTM)
Annual

Average

-6.16

Median

-5.20

Minimum

-20.12

Maximum

-0.35

Applied Therapeutics, Inc. (APLT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Applied Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 569.62%

Maximum Annual PE Ratio = -0.35

Minimum Annual Increase = -83.93%

Minimum Annual PE Ratio = -20.12

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.36569.62%
2022-0.35-83.93%
2021-2.19-57.86%
2020-5.20-32.59%
2019-7.7147.89%
2018-5.21-74.08%

Applied Therapeutics, Inc. (APLT) Average PE Ratio

How has APLT PE Ratio performed in the past?

The current PE Ratio of Applied Therapeutics, Inc. (APLT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.63

5-year avg

-3.56

10-year avg

-6.16

Applied Therapeutics, Inc. (APLT) PE Ratio vs. Peers

How is APLT’s PE Ratio compared to its peers?

Applied Therapeutics, Inc.’s PE Ratio is less than X4 Pharmaceuticals, Inc. (-1.50), less than Galera Therapeutics, Inc. (-0.10), greater than Terns Pharmaceuticals, Inc. (-6.02), greater than Day One Biopharmaceuticals, Inc. (-5.55), less than HOOKIPA Pharma Inc. (-1.86), less than Lyra Therapeutics, Inc. (-0.24), greater than Shattuck Labs, Inc. (-2.73), less than Vincerx Pharma, Inc. (-0.34), less than BioAtla, Inc. (-0.65), less than Gain Therapeutics, Inc. (-1.09), less than TFF Pharmaceuticals, Inc. (-0.23), less than aTyr Pharma, Inc. (-2.33), less than IN8bio, Inc. (-1.39), greater than Lantern Pharma Inc. (-2.87), greater than Anebulo Pharmaceuticals, Inc. (-5.68), less than Acrivon Therapeutics, Inc. Common Stock (-2.34), less than PMV Pharmaceuticals, Inc. (-1.27), greater than Molecular Partners AG (-3.99), greater than Mineralys Therapeutics, Inc. (-5.83), less than Seer, Inc. (-1.30), greater than ORIC Pharmaceuticals, Inc. (-4.75), greater than Cullinan Oncology, Inc. (-5.46), less than C4 Therapeutics, Inc. (-2.21),

Build a custom stock screener for Applied Therapeutics, Inc. (APLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied Therapeutics, Inc. (APLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Applied Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Applied Therapeutics, Inc. (APLT)?

What is the highest PE Ratio for Applied Therapeutics, Inc. (APLT)?

What is the 3-year average PE Ratio for Applied Therapeutics, Inc. (APLT)?

What is the 5-year average PE Ratio for Applied Therapeutics, Inc. (APLT)?

How does the current PE Ratio for Applied Therapeutics, Inc. (APLT) compare to its historical average?